Hydrogel Patent Trends: Leading Innovators, Top Jurisdictions and More

 Due to their high water content, softness, flexibility, and biocompatibility, hydrogels have become extremely popular in the medical industry, particularly in implants and drug delivery systems. As a result, the market for hydrogel-based medicine delivery systems saw value growth between 2017 and 2021 at a CAGR of 7.7%. Many organisations from around the world are developing new hydrogel products, including Boston Scientific, AbbVie, the University of California, and MIT (Massachusetts Institute of Technology). Recent years have seen an increase in IP filings in this field, with a greater emphasis on the materials and coatings used in prosthetics, which suggests increased study into implant materials.

The expansion of the hydrogel implant market, IP analysis, and current developments in drug hydrogel implants are all covered in this article.

Drug Implants and Hydrogel

Drug implants are implantable devices that use polymer materials to deliver medications to a specific place. They fall under the category of remote-controlled drug depots, which are useful devices for dispensing medication and releasing it in a controlled manner over a set period of time. Along with making the medications more effective and tolerable, it might also make the administration of the drugs simpler. Due to issues with immune tolerance, sequestration, and other issues that may occur from increased drug metabolism, varying concentrations of the medication delivered in blood, etc., the use of these implants has become necessary. By synchronising releasing vaccine components from implants over a predetermined time period, these issues can be managed. To address these issues, controlled drug delivery systems are necessary. These controlled drug depots frequently take the form of nanoparticles, hydrogels, and liposomes.

In recent years, hydrogels have become more widely used as drug delivery vehicles. They are colloidal compounds made of water and solids that have a high absorption capacity and include more than 90% water. Additionally, there are many benefits to employing hydrogels in drug delivery systems. For instance, they are biocompatible and don't break down until they're catalysed to do so inside the body. Patients can consume a tablet or medication that serves as a trigger, causing this gel implant under their skin to provide one dose of a vaccine or treatment.

Types of Hydrogel

Polymers are used to create hydrogels, which can be broadly divided into three categories based on the type of polymer used:

Natural Hydrogels: Natural hydrogels are formed of polysaccharides like chitosan, hyaluronic acid, and alginate as well as proteins including gelatin, lysosomes, collagen, and gelatin. These natural hydrogels exhibit strong cell adhesion abilities but suffer from mechanical instability, which limits their utility in drug delivery systems. With 32.3% of total sales, the natural category dominated the market for hydrogel-based drug delivery systems in 2020.

Synthetic Hydrogels: Poly (vinyl pyrrolidone), poly (acrylic acid), and poly (vinyl pyrrolidone) starch are some of the ingredients used to make synthetic hydrogels. Compared to natural hydrogels, they have become more well-liked in the industry because of their enhanced mechanical qualities, higher drug absorption capacity, controlled degradation features, and longer lifetime.

Hybrid hydrogels: These advanced, stimuli-responsive, intelligent hydrogels were created by combining natural and artificial hydrogels. The hybrid category dominated the market for hydrogel-based drug delivery systems in 2021 with a 6.6% CAGR. Their widespread usage in medicine is currently being researched.

In addition, porous (macro-pores of 10-500 m) and non-porous architectures can be used to distinguish amongst hydrogels. The size and porous nature of the hydrogels affect how they can be injected, implanted, or otherwise delivered into the human body.

Hydrogel Implant Applications

One of the promising ways to combat diseases like cancer is through vaccinations. However, the clinical efficacy of the currently known cancer vaccines is severely constrained by the lack of ideal delivery methods to generate strong and long-lasting antitumor immune responses. Additionally, limited patient compliance is caused by the fact that the majority of cancer vaccines require multiple doses to elicit immune responses. Controlled-release drug delivery methods, such as hydrogels, can address these issues by dispensing drugs in a controlled manner. It permits the co-administration of many medicines, lowers dose frequency, and prevents severe systemic toxicity.

Two million women are typically diagnosed with breast cancer each year, and the treatment frequently entails the removal of at least one breast. The majority of women decide against having their breasts rebuilt, though. In the new era of 3D-printed implants, hydrogels can stimulate the growth of new breast tissue before they entirely deteriorate. This treatment frequently employs silicon, although it can have negative effects in rare lymphomas that have the potential to be fatal. A hydrogel-based implant that gradually colonises the patient's fat cells and helps women regain their breasts in six to nine months has been created by regenerative medicine biotech business Healshape.

Dextenza is a human-use ocular therapeutic formulation employing hydrogel implant that was recently given FDA approval. It is used to alleviate ocular discomfort right away following eye surgery. Since typical ophthalmic eye drops have problems delivering medication over time and ocular discharge results in a major portion of pharmaceuticals being squandered instantly, the drug, produced by Ocular Therapeutix, had a big impact on the market.

Similar to this, a group of researchers at NYU developed an injectable hydrogel to delay the onset of post-traumatic osteoarthritis (PTOA). The polymer gel is composed of polypeptides, proteins, and the anti-inflammatory growth factor Atsttrin. Together, they build a network that promotes recovery and regeneration.

These gels are combined with medications to treat conditions related to the mouth cavity, such as gum diseases and fungal infections, because they have strong adhesion and stability capabilities with the mucosal cavity. Despite these tremendous advantages, hydrogels are expensive and difficult to make hydrogels with a consistent surface area, which may make them less acceptable.

Major Market Growth Factors of Hydrogel

The usage of hydrogel implants/vaccines has expanded for a number of reasons. Some of these development factors are as follows:

Hydrogels have gained popularity due to their ability to safely carry substances to their intended locations, produce the desired therapeutic benefits, and minimise adverse side effects.

R&D on various clinical diseases: There is a large demand for better drugs, vaccines, and therapies as a result of technological breakthroughs, global R&D on various clinical diseases, and the rising prevalence of chronic diseases. Additionally, in the past three years, the Covid-19 outbreak has increased the amount of clinical trials and vaccine development. A vaccine with neutralising antibody responses against SARS-CoV-2 was created using a hydrogel-based gradual release of a receptor-binding domain component.

Significant Factors Limiting the Market Growth of Hydrogel Implants

Despite the numerous benefits of hydrogel implants and vaccines, their commercial expansion is being constrained by the challenging development of these hydrogel-based drug delivery systems with consistent surface area. Additionally, because of their intricate architecture, businesses find it challenging to produce these systems for later usage. In addition to these characteristics, there are numerous more difficulties that significantly impede the therapeutic application of hydrogel systems. These include the ability to adjust practically, high development and manufacture costs, favourable regulatory frameworks, and more.

Due to the variety of drug hydrogel implant scaffolds available, regulatory classification and approvals, such as Food and Drug Administration (FDA) approval, are challenging. These elements prolong the already drawn-out FDA approval processes for their market entry and observation.

Integrating hydrogel systems in large-scale systems requires sound and well-defined production procedures. Additionally, these procedures can increase predictability across a range of variables, including safety profiles, skill, and reproducibility. However, the majority of these technologies only function at a pilot scale at the moment.

Consumer Trend in Hydrogel Drug Market

Market value for hydrogel-based pharmaceutical delivery systems increased 7.7% between 2017 and 2021. The global macromolecule hydrogel market is anticipated to increase from USD 475.7 million in 2020 to USD 578 million by 2026. This industry expanded significantly as a result of the COVID-19 pandemic.

A 2019 NCBI (National Center for Biotechnology Information) research found that, excluding contact lens trials, hydrogel was utilised in 223 clinical studies for therapeutic or diagnostic purposes. A total of 166 bulk hydrogels, 99 patch hydrogels, and 8 hydrogel coils were employed in the 223 clinical investigations.

IP Analysis and Trends in Hydrogel Patent

The development of new methods for treating various ailments has resulted in....

To know more, read the entire article about Hydrogel Patent.